Dehydroepiandrosterone substitution in women

Journal of Endocrinological Investigation

Volumn 22, Issue 10 SUPPL. 1, 1999, Pages 29-31

  Allolio, B ^a,b   Callies, F ^a   Arlt, W ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Schwerpunkt Endokrinologie   (Germany)

Author keywords

Adrenal insufficiency; Dehydroepiandrosterone; Dehypiandrosterone sulfate

Indexed keywords

PRASTERONE;

ADRENAL INSUFFICIENCY; DOSE RESPONSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; REVIEW;

ADRENAL INSUFFICIENCY; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS;

EID: 0033251964     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Baulieu E.E. Dehydroepiandrosterone (DHEA): a fountain of youth? J. Clin. Endocrinol. Metab. 1996, 81: 3147-3151.
2. Cutler G.B., Glenn M., Bush M., Hodgen G.D., Graham C.E., Loriaux D.L Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology 1978, 103:2112-2118.
3. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59: 551-555.
4. Svec F., Porter J.R. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc. Soc. Exp. Biol. Med. 1998, 278; 174-191.
5. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advanced age. J. Clin. Endocrinol. Metab. 1994, 78:1360-1367.
6. Casson P.R., Andersen R.N., Herrod H.G., Stentz F.B., Straughn A.B., Abraham G.E., Buster J.E. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynecol. 1993, 1069:1536-1539.
7. Casson P.R., Faquin L.C., Stentz F.B., Straughn A.B., Andersen R.N., Abraham G.E., Buster J.E. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil. Steril. 1995, 63:1027-1031.
8. Yen S.S.C., Morales A.J., Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects.Ann. NY. Acad. Sci. 1995, 774:128-142.
9. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A., Candas B. Effect of 12-month replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab. 1997, 82:3498-3505.
10. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S.C. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 1998, 49:421-432.
11. Casson P.R., Santoro N., Elkind-Hirsch K., Carson S.A., Hornsby P.J., Abraham G., Buster J.E. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil. Steril. 1998, 70: 107-110.
12. Arlt W., Justl H.G., Callies F., Reincke M., Hubler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 1998, 83:1928-1934.
13. Callies F., Arlt W., Siekmann L., Huebler D., Bidlingmaier F., Allolio B. Influence of oral dehydroepiandrosterone (DHEAS) on urinary steroid metabolites in males and females. Steroids 1999 (in press).
14. Young J., Couzinet B., Nahoul K., Brailly S., Chanson P., Baulier E.E., Schaison G. Panhypopoituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J. Clin. Endocrinol. Metab. 1997, 82:2578-2585.
15. Arlt W., Callies F., van Vlijmen J. C., Koehler I., Reincke M., Bidlingmaier M., Huebler D., Oettel M., Ernst M., Schulte H. M., Allolio M. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 1999, 341, 14:1013-1020.
16. Majewska M.D., Demirgoeren S., Spivak C.E., London E.D. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990, 526:143-146.
17. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. USA 1998, 95:4678-4683.